Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts

A Single Technology Appraisal

Ruben Mujica Mota, Jo Varley-Campbell, Irina Tikhonova, Chris Cooper, Martin Hoyle, Claudius Rudin, Tristan Snowsill

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherUniversity of Exeter
Commissioning bodyThe National Institute for Health and Care Excellence (NICE)
Number of pages145
Publication statusPublished - 2016
Externally publishedYes

Cite this

Mujica Mota, R., Varley-Campbell, J., Tikhonova, I., Cooper, C., Hoyle, M., Rudin, C., & Snowsill, T. (2016). Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts: A Single Technology Appraisal. University of Exeter.